RFC
BMRN icon

Regions Financial Corp’s BioMarin Pharmaceuticals BMRN Stock Holding History

Regions Financial Corp’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,985
Closed -$245K – 807
2020
Q2 		$245K Sell
1,985
-429
-18% -$42.6K ﹤0.01% 696
2020
Q1 		$204K Sell
2,414
-186
-7% -$16K ﹤0.01% 716
2019
Q4 		$220K Buy
+2,600
New +$196K ﹤0.01% 763
2019
Q3 		– Sell
-2,870
Closed -$246K – 815
2019
Q2 		$246K Sell
2,870
-137
-5% -$11.7K ﹤0.01% 721
2019
Q1 		$267K Buy
3,007
+453
+18% +$42K ﹤0.01% 698
2018
Q4 		$217K Sell
2,554
-108
-4% -$10.3K ﹤0.01% 742
2018
Q3 		$258K Buy
2,662
+324
+14% +$32.3K ﹤0.01% 758
2018
Q2 		$221K Buy
2,338
+41
+2% +$3.59K ﹤0.01% 791
2018
Q1 		$187K Hold
2,297
– – ﹤0.01% 853
2017
Q4 		$205K Sell
2,297
-27
-1% -$2.35K ﹤0.01% 842
2017
Q3 		$216K Buy
+2,324
New +$205K ﹤0.01% 821
2014
Q4 		– Sell
-23,500
Closed -$1.7M – 943
2014
Q3 		$1.7M Sell
23,500
-1,675
-7% -$110K 0.02% 401
2014
Q2 		$1.57M Buy
25,175
+6,125
+32% +$370K 0.02% 459
2014
Q1 		$1.3M Sell
19,050
-1,000
-5% -$73.7K 0.02% 506
2013
Q4 		$1.41M Sell
20,050
-890
-4% -$60.4K 0.02% 453
2013
Q3 		$1.51M Sell
20,940
-4,200
-17% -$279K 0.02% 390
2013
Q2 		$1.4M Buy
+25,140
New +$1.57M 0.02% 381

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Regions Financial Corp's BMRN Position: Q3 2020 in Review

Regions Financial Corp sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2020, closing a stake of 1,985 shares — an estimated $245K sold.

Regions Financial Corp first reported a position in BMRN in Q2 2013 and held it in 17 quarters. The position peaked at $1.7M in Q3 2014. 496 funds tracked by Wall St. Rank hold BMRN as of Q3 2020.

  • Regions Financial Corp reported no remaining BioMarin Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Regions Financial Corp sold 1,985 BioMarin Pharmaceuticals shares in Q3 2020, an estimated $245K.
  • Regions Financial Corp first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Regions Financial Corp's BioMarin Pharmaceuticals position peaked at $1.7M in Q3 2014.
  • 496 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2020.

Based on Regions Financial Corp's 13F filing for Q3 2020, filed 15 Oct 2020.